Blood cancers

PBS restrictions relaxed for multiple myeloma patients

From today people living with relapsed refractory multiple myeloma will no longer be required to use thalidomide prior to gaining access to lenalidomide (Revlimid) through the PBS. Lenalidomide in combination with dexamethasone has been available as a first line treatment for patients not eligible for transplant since 2017 and as a third line treatment since ...

Already a member?

Login to keep reading.

© 2021 the limbic